• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非精原细胞瘤性睾丸生殖细胞肿瘤睾丸切除术后的主动监测:可能发生晚期复发。

Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.

作者信息

Boyer M J, Cox K, Tattersall M H, Findlay M P, Grygiel J, Rogers J

机构信息

Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown NSW, Australia.

出版信息

Urology. 1997 Oct;50(4):588-92. doi: 10.1016/S0090-4295(97)00301-4.

DOI:10.1016/S0090-4295(97)00301-4
PMID:9338737
Abstract

OBJECTIVES

To review the outcome of men with Stage I nonseminomatous germ cell tumors managed with a policy of active surveillance following orchiectomy.

METHODS

The clinical records of all men with Stage I nonseminomatous germ cell tumors seen at Royal Prince Alfred Hospital, Australia between 1982 and 1995 were reviewed. Data were obtained concerning the histologic type of tumor, levels of serum tumor markers, relapse and subsequent treatment, and survival.

RESULTS

Seventy-seven patients were entered into the active surveillance protocol between 1982 and 1995. With a minimum follow-up of 2 years, 27 (35%) have relapsed, with a median time to relapse of 5 months. Two late relapses occurred at 37 and 57 months after diagnosis. Relapses occurred most commonly in the retroperitoneal lymph nodes, with the lungs the second most common site. Following treatment with chemotherapy and surgery, all patients achieved complete remission, with 1 patient subsequently relapsing and ultimately dying of progressive tumor. One other patient died of acute myeloid leukemia, thought to be secondary to chemotherapy. Overall, 75 patients (97%) remain alive and free of disease.

CONCLUSIONS

Active surveillance is a safe and effective approach to the management of Stage I nonseminomatous germ cell tumors. Although most relapses occur within the first 2 years, late relapses may occur.

摘要

目的

回顾接受睾丸切除术后采用主动监测策略治疗的I期非精原细胞瘤性生殖细胞肿瘤男性患者的治疗结果。

方法

回顾了1982年至1995年间在澳大利亚皇家阿尔弗雷德王子医院就诊的所有I期非精原细胞瘤性生殖细胞肿瘤男性患者的临床记录。获取了有关肿瘤组织学类型、血清肿瘤标志物水平、复发及后续治疗情况以及生存情况的数据。

结果

1982年至1995年间,77例患者进入主动监测方案。在至少2年的随访中,27例(35%)复发,复发的中位时间为5个月。诊断后37个月和57个月各发生1例晚期复发。复发最常见于腹膜后淋巴结,肺部是第二常见部位。经过化疗和手术治疗后,所有患者均实现完全缓解,1例患者随后复发并最终死于肿瘤进展。另1例患者死于急性髓系白血病,被认为是化疗的继发结果。总体而言,75例患者(97%)仍存活且无疾病。

结论

主动监测是治疗I期非精原细胞瘤性生殖细胞肿瘤的一种安全有效的方法。虽然大多数复发发生在头2年内,但也可能发生晚期复发。

相似文献

1
Active surveillance after orchiectomy for nonseminomatous testicular germ cell tumors: late relapse may occur.非精原细胞瘤性睾丸生殖细胞肿瘤睾丸切除术后的主动监测:可能发生晚期复发。
Urology. 1997 Oct;50(4):588-92. doi: 10.1016/S0090-4295(97)00301-4.
2
Late relapse of metastatic testicular nonseminomatous germ cell cancer: surgery is needed for cure.转移性睾丸非精原细胞瘤的晚期复发:治愈需要手术治疗。
BJU Int. 2006 Aug;98(2):353-8. doi: 10.1111/j.1464-410X.2006.06250.x.
3
Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors.具有高危因素的临床I期睾丸非精原性恶性生殖细胞肿瘤患者辅助化疗后的长期结果。
J Urol. 1999 Apr;161(4):1148-52.
4
A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup.
J Urol. 1995 Sep;154(3):1045-9.
5
Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified?临床I期非精原细胞瘤性生殖细胞肿瘤监测方案的结果——转向风险适应性策略是否合理?
J Urol. 2006 Oct;176(4 Pt 1):1424-29; discussion 1429-30. doi: 10.1016/j.juro.2006.06.012.
6
[Management of stage I testicular nonseminomatous germ cell tumors with an embryonic carcinomatous component. 18 cases].[伴有胚胎癌成分的Ⅰ期睾丸非精原细胞瘤的治疗。18例]
Prog Urol. 1997 Sep;7(4):622-7.
7
Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.睾丸临床I期非精原细胞性生殖细胞肿瘤保留神经的腹膜后淋巴结清扫术的并发症:德国睾丸癌研究组的经验
J Urol. 2003 May;169(5):1710-4. doi: 10.1097/01.ju.0000060960.18092.54.
8
Compliance and outcome of patients with stage 1 non-seminomatous germ cell tumors (NSGCT) managed with surveillance programs in seven Canadian centres.加拿大七个中心采用监测方案管理的Ⅰ期非精原性生殖细胞肿瘤(NSGCT)患者的依从性和结局
Can J Urol. 2005 Apr;12(2):2575-80.
9
[Urologic treatment of testicular germ cell cancer].睾丸生殖细胞癌的泌尿外科治疗
Arch Esp Urol. 2002 Oct;55(8):927-36.
10
Surveillance following orchiectomy for stage I testicular seminoma: long-term outcome.I期睾丸精原细胞瘤睾丸切除术后的监测:长期结果
Int J Urol. 2009 Sep;16(9):756-9. doi: 10.1111/j.1442-2042.2009.02355.x. Epub 2009 Jul 29.

引用本文的文献

1
Late Testicular Yolk Sac Tumor With Cerebellar Metastasis and a Rapid Recurrence After a Gross Total Resection: A Case Report.晚期睾丸卵黄囊瘤伴小脑转移及全切除术后快速复发:1例报告
Cureus. 2021 Aug 13;13(8):e17143. doi: 10.7759/cureus.17143. eCollection 2021 Aug.
2
Canadian consensus guidelines for the management of testicular germ cell cancer.加拿大睾丸生殖细胞癌管理共识指南
Can Urol Assoc J. 2010 Apr;4(2):e19-38. doi: 10.5489/cuaj.815.
3
High risk NSGCT: case for surveillance.高危非精原细胞瘤性生殖细胞肿瘤:监测病例
World J Urol. 2009 Aug;27(4):441-7. doi: 10.1007/s00345-009-0453-6. Epub 2009 Jul 16.
4
Treatment of stage I testicular germ-cell tumors.I 期睾丸生殖细胞肿瘤的治疗。
Med Oncol. 2006;23(3):305-15. doi: 10.1385/MO:23:3:305.